Literature DB >> 2579625

Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.

L Volicer, L K Direnfeld, M Freedman, M L Albert, P J Langlias, E D Bird.   

Abstract

Serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels were measured in the sixth, 13th, and 20th milliliters of CSF in patients with dementia of the Alzheimer's type (DAT) and Parkinson's disease (PD), and in an aliquot of CSF in controls. In patients with PD there was a positive correlation between 5-HT and 5-HIAA levels in the 20th milliliter of CSF, while in patients with DAT there was a negative correlation of these levels in this CSF fraction. In patients with the senile form of DAT the 5-HIAA levels in the 20th milliliter of CSF were higher than in patients with PD. These results indicate differential involvement of the serotoninergic system in DAT and PD, and may lead to the development of a chemical marker for DAT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579625     DOI: 10.1001/archneur.1985.04060020037011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 2.  Recent advances in the application of metabolomics to Alzheimer's Disease.

Authors:  Eugenia Trushina; Michelle M Mielke
Journal:  Biochim Biophys Acta       Date:  2013-06-29

3.  Liquid chromatographic assay for cerebrospinal fluid serotonin.

Authors:  M Linnoila; K A Jacobson; T H Marshall; T L Miller; K L Kirk
Journal:  Life Sci       Date:  1986-02-24       Impact factor: 5.037

4.  Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.

Authors:  T Sunderland; P N Tariot; R M Cohen; P A Newhouse; A M Mellow; E A Mueller; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

6.  Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase.

Authors:  Joyce H Hurley; Shengwen Zhang; Leighan S Bye; Mark S Marshall; Anna A DePaoli-Roach; Kunliang Guan; Aaron P Fox; Lei Yu
Journal:  BMC Neurosci       Date:  2003-06-09       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.